Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q2- Text added to 2023 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
New words:
add, Canadian, cannabinol, chronic, dba, demand, diversity, enroll, Europe, experiencing, formation, inhibit, legacy, letter, medication, Montreal, neurofibrillary, North, peptide, phosphorylation, population, promoting, prompting, registered, registration, shelf, site, sought, suppressing, syndrome, tau, thereof, uncertain, underrepresented, unprecedented, vitro
Valuein 2023 Q2 filing- Value in 2023 Q3 filing
Original filings
Filing view